NCT02140736 Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology Status COMPLETED Phase N/A
NCT02135510 MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy Status COMPLETED Phase PHASE3
NCT02130466 A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022) Status COMPLETED Phase PHASE1/PHASE2
NCT02122809 Phase I Study of Chiauranib in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02120118 Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors Status WITHDRAWN Phase PHASE2
NCT02116803 An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective Status COMPLETED Phase PHASE2/PHASE3
NCT02110563 Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma Status TERMINATED Phase PHASE1
NCT02100007 ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02095951 Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection Status COMPLETED Phase PHASE4
NCT02091141 My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE2
NCT02082626 Study of Eribulin in Children With Cancer to Determine Safety Status TERMINATED Phase PHASE1
NCT02071537 Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02063230 To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects Status COMPLETED Phase PHASE1
NCT02058901 Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors. Status COMPLETED Phase PHASE1
NCT02052492 Safety Study of EF-022 ( Modified Vitamin D Binding Protein Macrophage Activator) in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02048488 A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas Status COMPLETED Phase PHASE1/PHASE2